netFormulary

North East and North Cumbria
ICS Formulary

19 Miscellaneous Preparations [non-BNF and Unlicensed Drugs]

19 Miscellaneous

NTAG Biosimilar Statement

Acetic acid 5%

Formulary

T o be diluted to 2.5%
- approved for the use in the detection of dysplasia/ neoplasia
in Barrett’s oesophagus

Alkaline Nasal Douche

Formulary

Baclofen Intrathecal

Formulary

Bisacodyl 0.274% rectal soln

Formulary

Clonidine Intrathecal Injection

Formulary

Co-Careldopa liquid

Formulary

Codeine Phosphate Suppositories

Formulary

Diphencyprone in acetone

Formulary

Ferric Subsulphate (Monsel’s Soln) 50ml

Formulary

Glycopyrrolate 0.5% in Cetomacrogol A

Formulary

LAT Gel

Formulary

Low dose Naltrexone

Formulary

Magnesium sulphate 10% solution for injection pre-filled syringe

Formulary

Onasemnogene abeparvovec Zolgenmsa^®

Formulary

Approved for the treatment of spinal muscular atrophy in line with NICE

NICE HST15: Onasemnogene abeparvovec for treating spinal muscular atrophy

Phenazopyridine tablets

Formulary

Phenol (aqueous) Injection 6%

Formulary

Stanozolol 2mg tabs

Formulary

Sulphur hexafluoride Sonovue^®

Formulary

Sulphur hexafluoride. Available as a kit including one vial of gas, one vial of powder and one pre-filled syringe containing 5ml of solvent. On reconstitution, 1 ml of the resulting dispersion contains 8 microliters of sulphur hexafluoride in the microbubbles, equivalent to 45 microgrammes

Approved for use in visualising blood vessels in liver and diagnosing cancer, and used for the diagnosis of pancreatic cancers, and also for use when echocardiography images are unsatisfactory for answering the clinical question due to poor definition.

Volanesorsen Waylivra^®

Formulary

Approved for treating familial chylomicronaemia syndrome in adults in line with NICE

NICE HST 13: Volanesorsen for treating familial chylomicronaemia syndrome

Links